PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung Cancer
Open Access
- 1 May 2015
- journal article
- molecular bases-of-disease
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 290 (21) , 13479-13489
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01CA138528)
This publication has 48 references indexed in Scilit:
- Loss of the major Type I arginine methyltransferase PRMT1 causes substrate scavenging by other PRMTsScientific Reports, 2013
- Dishevelled3 is a novel arginine methyl transferase substrateScientific Reports, 2012
- Candidate exome capture identifies mutation of SDCCAG8 as the cause of a retinal-renal ciliopathyNature Genetics, 2010
- Protein Arginine Methylation in Mammals: Who, What, and WhyMolecular Cell, 2009
- Loss of E-Cadherin Promotes Metastasis via Multiple Downstream Transcriptional PathwaysCancer Research, 2008
- Twist is a transcriptional repressor of E-cadherin gene expression in breast cancerBiochemical and Biophysical Research Communications, 2008
- Expression of Twist increases the risk for recurrence and for poor survival in epithelial ovarian carcinoma patientsBritish Journal of Cancer, 2007
- Upregulation of Twist in oesophageal squamous cell carcinoma is associated with neoplastic transformation and distant metastasisJournal of Clinical Pathology, 2006
- PABP1 identified as an arginine methyltransferase substrate using high‐density protein arraysEMBO Reports, 2002
- The Mammalian Immediate-early TIS21 Protein and the Leukemia-associated BTG1 Protein Interact with a Protein-arginine -MethyltransferaseJournal of Biological Chemistry, 1996